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Background: Nitric oxide (NO) in the respiratory tract is an important regulator of 
pulmonary homeostasis during the perinatal transition. In humans, much of the nitric 
oxide is derived from the upper airways, and autoinhalation of nasal NO has been 
suggested to influence pulmonary function. No standard methods for measuring 
nasal NO in neonates currently exist, and previous studies have reported varying 
levels of nasal nitric oxide in infants, due to the different measuring methods used. 
The use of nasal olives with a central lumen placed securely in the nares was rec-
ommended as a standardized procedure for the measurement of nasal NO in adults 
and children in 1999. We attempted to establish a safe, convenient and practical 
method for measuring nasal NO in healthy newborn infants, and investigated possi-
ble correlations between nasal NO and gender, postnatal age, gestational age, birth 
weight, and the differences between the right and left nostrils.
Methods: Nasal NO was studied in healthy newborn infants within the first 3 postnatal 
days. Gas was sampled from the nostril, and NO concentrations were determined using 
a fast response chemiluminescence analyzer. Each newborn infant underwent NO 
measurements on the first, second and the third postnatal days. Ninety-one newborn 
infants completed the study.
Results: Peak nasal NO in 91 newborn infants was 42.52 ± 16.82 (mean ± SD) parts per 
billion (ppb) (right nostril) and 40.86 ± 16.08 ppb (left nostril) on the first postnatal 
day, 48.75 ± 17.64 ppb (right nostril) and 49.47 ± 17.26 ppb (left nostril) on the second 
postnatal day, and 59.65 ± 19.72 ppb (right nostril) and 59.29 ± 20.09 ppb (left nostril) 
on the third postnatal day. Nasal NO increased significantly with postnatal age 
(p < 0.001). There were no significant differences in nasal nitric oxide between sexes, 
or in relation to gestational age or birth weight, or between left or right nostrils.
Conclusion: We conclude that nasal NO increased significantly in the first 3 days 
of life.
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1. Introduction
Nitric oxide (NO) is produced endogenously within 
the respiratory tract and was first detected in ex-
haled air in humans and mammals in 1991.1 Measure-
ment of exhaled NO has been proposed as a new 
test for pulmonary function that could be used to 
monitor airway inflammation in asthma and other 
inflammatory respiratory disorders.2 Most of the NO 
in adults and children originates from the upper 
respiratory tract, especially the paranasal sinuses.3,4 
The physiologic role of nasal NO is still unclear, but 
it has been suggested that it acts as a regulator 
of pulmonary homeostasis in humans and plays 
an important role during perinatal adaptation in 
neonates.5,6 No standard methods for measuring 
nasal NO in neonates are currently available, and 
procedures using velum closure to either prevent 
the loss of nasal NO via the posterior velopharyngeal 
aperture, or entry of lower respiratory air into the 
nasal cavity, are difficult to perform in neonates.7 
The most accurate method of measuring NO con-
centrations in the upper and lower respiratory 
tracts in infants is by sampling in intubated infants, 
though this is often inconvenient or impractical.8,9 
Nasal olives, with a central lumen placed securely in 
the nares, were recommended as the standardized 
procedure for the measurement of nasal NO in adults 
and children in 1999.10
Measurements of nasal NO concentrations are 
helpful for screening children with clinical symptoms 
suggestive of primary ciliary dyskinesia (PCD), and to 
aid decisions on the need for further, more invasive 
testing.11 The early measurement of nasal NO con-
centrations may be helpful for screening neonates 
with PCD.
In this study, we attempted to establish a safe, 
convenient and practical method of measuring nasal 
NO in healthy newborn infants. We also investigated 
possible correlations between nasal NO and gender, 
postnatal age, gestational age, birth weight, and 
differences between the right and left nostrils.
2. Materials and Methods
This prospective study was conducted in infants 
cared for in our hospital nursery between July 1, 
2006 and May 31, 2007. One hundred and nine 
healthy term infants with normal birth weights 
were enrolled into the study after informed writ-
ten parental consent was obtained. The study was 
approved by the Tri-Service General Hospital Insti-
tutional Review Board. The mothers were all healthy, 
with histories of normal pregnancies. To detect 
any changes in measurable levels of endogenously 
produced NO in the upper airways during the first, 
second and third postnatal days, measurements 
were performed 24 hours, 48 hours and 72 hours 
after birth, in the nursery.
In non-cooperative children, nasal NO can be 
measured during normal tidal breathing if sedation 
is not to be used.12,13 The infants were studied while 
lying in their cots, with a room air temperature of 
24−25ºC. During the study period, the NO concen-
trations in the ambient air were always below 5 parts 
per billion (ppb). A bead was inserted approximately 
5 mm inside one nostril (right first), ensuring a tight 
seal, while the contralateral nostril was left open. 
The bead was made of a smooth, non-traumatizing 
material, and was of a sufficient diameter and 
appro priate size to occlude the nares (Figure 1). 
Figure 1 Appropriate sizes of beads introduced to occlude nares for nasal aspiration.
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Measure ments were performed during regular tidal 
breathing, with the neonates lying quietly in the su-
pine position with mouths closed. The results were 
considered acceptable only if a stable plateau of at 
least 10 seconds was achieved. Measurements were 
performed at least three times in both the right 
and left nostrils. This technique for sampling nasal 
NO is similar to that reported previously by Schedin 
et al.14 The bead was connected by a Teflon tube 
to a suction pump with a side port connecting to 
the NO analyzer. The levels of nasal NO were mea-
sured using a fast response (0.02 seconds) chemilu-
minescence analyzer (NOA 280; Sievers Instruments, 
Inc., Boulder, CO, USA). The sampling flow rate was 
200 mL/minute. NO levels were simultaneously dis-
played on the front panel of the analyzer and on 
a computer attached to the RS-232 output. Data 
were stored and analyzed using computer software 
(NO Analysis 3.21 BREATH; Sievers Instruments, Inc.). 
A 2-point calibration was performed daily, first to 
zero with air passing through an NO scrubber tube 
containing KMnO4 (potassium permanganate) and 
activated charcoal, and then with certified stan-
dardized NO gas (9.45 ppm) for the span (Linde Gas 
LLC; Maumee Specialty Gas Plant, Maumee, OH, 
USA). The amount of NO in the ambient air (baseline) 
was recorded before each measurement. We present 
the data for peak nasal NO concentrations, i.e., 
for each peak level detected in the plateau periods 
(Figure 2). The peak nasal NO level was the maximal 
value for the exhalation, as calculated by the soft-
ware. Within-subject variation in NO levels was 
quantified in 31 subjects. A series of nasal NO ex-
aminations was performed in the same nostril, 
which revealed no significant differences (Table 1). 
Our methods were therefore reproducible.
Data were analyzed using Sigma Stat (Version 
3.1, SPSS, Chicago, IL, USA). Statistical evaluation 
was performed using the paired t test and linear 
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Figure 2 A typical recording of nasal NO derived from an infant. Nasal sampling periods from right and left nostril 
(right first) and interspersed non-aspirated periods (−) are indicated by horizontal bars. Ambient air was aspirated 
during non-aspirated periods. A postocclusive nasal NO maximal level (large arrow) followed by a plateau period 
(small arrow) was shown.
Table 1  Within-group variation based on three mea-
surements in each nostril in 31 subjects
Nostril Nasal NO p
Day 1 R 46.55 ± 18.72 0.158
 46.65 ± 18.64
 46.68 ± 18.66
Day 1 L 45.17 ± 18.55 0.804
 45.23 ± 18.46
 45.21 ± 18.49
Day 2 R 61.30 ± 26.26 0.179
 61.23 ± 26.30
 61.42 ± 26.19
Day 2 L 60.86 ± 27.77 0.369
 60.72 ± 27.63
 60.84 ± 27.57
Day 3 R 68.68 ± 24.62 0.507
 68.81 ± 24.73
 68.81 ± 24.51
Day 3 L 66.62 ± 27.64 0.384
 66.69 ± 27.71
 66.76 ± 27.67
*Mean ± SD.
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regression analysis. Data are reported as mean ± SD. 
Statistical significance was defined as p < 0.05.
3. Results
A total of 91 infants (46 male), with a median gesta-
tional age of 39.4 weeks (39.4 ± 1.2) and a median 
birth body weight of 3140.5 g (3140.5 ± 376), were 
entered into the study (Table 2). NO concentrations 
in the upper airways of the healthy newborn infants 
increased with postnatal age during the first 3 days 
of life. The ambient air NO concentrations were 
2.27 ± 0.3 ppb during the experiments. Peak nasal NO 
in the 91 newborn infants was 42.52 ± 16.82 (mean ± 
SD) ppb (right nostril) and 40.86 ± 16.08 ppb (left 
nostril) on the first postnatal day, 48.75 ± 17.64 ppb 
(right nostril) and 49.47 ± 17.26 ppb (left nostril) on 
the second postnatal day, and 59.65 ± 19.72 ppb (right 
nostril) and 59.29 ± 20.09 ppb (left nostril) on the 
third postnatal day (Figure 3). Peak nasal NO in-
creased significantly with postnatal age during the 
first 3 days, with the lowest levels on the first post-
natal day and the highest levels on the third postnatal 
day (p < 0.01). There was no significant difference 
in nasal NO between sexes, or in relation to gesta-
tional age or birth weight, or between and left and 
right nostrils.
4. Discussion
In this study, we developed a modified method of 
measuring NO concentrations in the upper airways 
of neonates, using a bead instead of an olive.12−14 
The vestibula of newborn infants are shorter and 
narrower than in adults, and a bead fitted the ves-
tibulum of neonates better than an olive. Newborn 
infants, like adults, excrete considerable amounts 
of NO through their nasal airways. NO concentra-
tions in the ppb range can be measured as early as 
the first postnatal day.
We measured the NO concentrations from nasal 
airways without the velum closure procedures rec-
ommended by the American Thoracic Society.10 
There is currently no validated non-invasive technique 
for measuring nasal NO concentrations in infants 
or young children who are unable to perform velum 
closure maneuvers. Our non-invasive method provides 
a safe, convenient and practical means of measuring 
NO concentrations in the nasal airway of newborns. 
The nasal-aspirated NO measured without velum clo-
sure procedures, included NO from both the upper 
and lower airways. However, most of the NO in ex-
haled air originates from the nasal airways, with 
only a minor contribution from the lower airways 
(< 5 ppb) and the oral cavity.8 The measured nasal 
NO concentrations were distinctly higher than those 
in the expired air from mechanically ventilated in-
fants.8 High concentrations of NO are found in the 
noses of neonates shortly after birth, even before 
the sinuses have developed.15 We thus considered 
that the NO measured reflected nasal concentra-
tions, and that these were already present in the 
ppb range on the first postnatal day, and possibly 
even earlier. We therefore introduced a non-invasive 
method for the detection of nasal NO concentra-
tions. This has been considered to play several hy-
pothetical roles, including enhancing non-specific 
host defense mechanisms, reducing pulmonary 
vascular resistance,16,17 modulating the pulmonary 
vascular tone as well as improving ventilation-
perfusion matching, regulating ciliary function,18 and 
being a surrogate marker of nasal inflammations 
such as allergic rhinitis.19
The plateau nasal NO levels have been thought to 
reflect a balance between NO production, absorption 
and removal of the sampling pump, and were not 
affected by breathing conditions or occlusion time.20 
Colnaghi et al measured the nasal NO plateau level 
using a higher sampling flow rate (1 L/min). Their 
results showed lower nasal NO levels than those found 
Table 2 Characteristics of healthy subjects (n = 91)
Male/female  46/45
Gestational age (wk) 39.4 ± 1.2*
Birth body weight (g) 3140.5 ± 376
*Mean ± SD.
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Figure 3 Average peak nasal NO concentrations (mean ± 
SD) in ppb. The peak nasal NO concentrations increased 
with postnatal ages (p < 0.01). There was no significant 
difference in NO concentrations between nostrils.
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in our study (10.91 ± 0.65 ppb vs. 53.02 ± 21.98 ppb). 
The authors also found that the nasal NO levels 
were significantly higher in term than in preterm 
infants.5 Schedin et al used a lower sampling flow 
rate (20 mL/minute) to evaluate the nasal NO con-
centration in healthy term neonates, and they an-
alyzed the changes of postocclusive nasal NO peak 
levels. The authors concluded that postocclusive 
peak nasal NO levels increased with postnatal age 
and occlusion time.14 In our study, we found that NO 
concentrations in the nasal aspirates increased with 
postnatal age. This provides additional information 
about the normal levels of NO present in the nasal 
airways of healthy newborn infants in Taiwan.
Screening may be performed for PCD. Measure-
ment of nasal NO concentrations in patients with 
PCD are extremely low compared with those in 
healthy children or children with other respiratory 
disorders,21,22 though the reason for this low nasal 
NO concentrations has not yet been clarified. Several 
observations suggest that NO plays an important 
role in signal transduction associated with ciliary 
motility.23 Measurements of nasal NO concentrations 
are helpful for screening infants with clinical symp-
toms suggestive of PCD, and can aid decisions on 
the need for further, more invasive testing.
In conclusion, we found that NO concentrations 
in the nasal airways of healthy newborn infants in-
creased with postnatal age during the first 3 days 
of life. There were no significant differences in nasal 
NO between sexes, or in relation to gestational age 
or birth weight, or between left and right nostrils.
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